Noven Therapeutics recalls

Noven Therapeutics has 7 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 29 Apr 2020. The most frequent reason is potency & assay.

Total recalls7since 2020

Last 12 months0reported

Class I00% of total

Ongoing0latest 29 Apr 2020

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 7 100%Class III 0 0%

Why noven therapeutics is recalled

Potency & Assay7100%

Product types

ADHD Medication7100%

By year

20207100%

All noven therapeutics recalls, newest first

7 total

Reported	Class	Recall	Company	Reason	Where
29 Apr 2020Drug	CLASS II	Daytrana (methylphenidate transdermal system) Delivers recalledDaytrana	Noven Therapeutics	Potency & Assay	Nationwide
29 Apr 2020Drug	CLASS II	Daytrana (methylphenidate transdermal system) Delivers recalledDaytrana	Noven Therapeutics	Potency & Assay	Nationwide
29 Apr 2020Drug	CLASS II	Daytrana (methylphenidate transdermal system) Delivers recalledDaytrana	Noven Therapeutics	Potency & Assay	Nationwide
25 Mar 2020Drug	CLASS II	Daytrana (methylphenidate transdermal system) patches recalledDaytrana	Noven Therapeutics	Potency & Assay	Nationwide
25 Mar 2020Drug	CLASS II	Daytrana (methylphenidate transdermal system) patches recalledDaytrana	Noven Therapeutics	Potency & Assay	Nationwide
25 Mar 2020Drug	CLASS II	Daytrana (methylphenidate transdermal system) patches recalledDaytrana	Noven Therapeutics	Potency & Assay	Nationwide
25 Mar 2020Drug	CLASS II	Daytrana (methylphenidate transdermal system) patches recalledDaytrana	Noven Therapeutics	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.